Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Position Overview SUEZ Air & Climate is strengthening its international climate services activity and is looking for a motivated, entrepreneurial and adaptable climate professional to support the growth and delivery of our climate change, resilience and
The company Norbert is building autonomous robots that deliver healthcare. Our AI sensing platform enables existing robotic platforms to become care team members: rounding on patients, capturing vitals without contact (FDA-cleared for pulse and respiratory rate,